Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin

Chest

Volumn 146, Issue 2, 2014, Pages 328-338

  Stolz, Daiana ^a   Boersma, Wim ^b   Blasi, Francesco ^c   Louis, Renaud ^d   Milenkovic, Branislava ^e,f   Kostikas, Kostantinos ^g   Aerts, Joachim G ^h,i   Rohde, Gernot ^j   Lacoma, Alicia ^k   Rakic, Janko ^a   Boeck, Lucas ^a   Castellotti, Paola ^c   Scherr, Andreas ^a   Marin, Alicia ^k   Hertel, Sabine ^l   Giersdorf, Sven ^l   Torres, Antoni ^m   Welte, Tobias ⁿ   Tamm, Michael ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Medical Centre Alkmaar   (Netherlands)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY OF BELGRADE   (Serbia)

^f CLINICAL CENTER OF SERBIA   (Serbia)

^g UNIVERSITY OF THESSALY   (Greece)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ AMPHIA HOSPITAL   (Netherlands)

^j MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^k HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^l THERMO FISHER SCIENTIFIC   (Germany)

^m UNIVERSITY OF BARCELONA   (Spain)

ⁿ HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROADRENOMEDULLIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN DESATURATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RISK ASSESSMENT; WALKING;

ADRENOMEDULLIN; AGED; ANOXIA; BIOLOGICAL MARKERS; DISEASE PROGRESSION; EUROPE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PHYSICAL EXERTION; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TIME FACTORS;

EID: 84905662415     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1967     Document Type: Article

References (53)

1. Tojo N, Ichioka M, Chida M, Miyazato I, Yoshizawa Y, Miyasaka N. Pulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary disease. Intern Med. 2005; 44 (1):20-25. (Pubitemid 40260036)
2. Casanova C, Cote C, Marin JM, et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest. 2008; 134 (4):746-752.
3. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008; 32 (5):1371-1385.
4. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):367-370. (Pubitemid 41699698)
5. Davidson AC, Leach R, George RJ, Geddes DM. Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax. 1988; 43 (12):965-971. (Pubitemid 19023758)
6. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010; 35 (4):913-922.
7. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003; 168 (9):1034-1042. (Pubitemid 37338931)
8. Jolly EC, Di Boscio V, Aguirre L, Luna CM, Berensztein S, Gené RJ. Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia. Chest. 2001; 120 (2):437-443. (Pubitemid 32881259)
9. Eaton T, Garrett JE, Young P, et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J. 2002; 20 (2):306-312.
10. Jensen G, Nielsen HB, Ide K, et al. Cerebral oxygenation during exercise in patients with terminal lung disease. Chest. 2002; 122 (2):445-450. (Pubitemid 35002119)
11. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med. 2006; 174 (4):373-378. (Pubitemid 44223116)
12. Panos RJ, Eschenbacher W. Exertional desaturation in patients with chronic obstructive pulmonary disease. COPD. 2009; 6 (6):478-487.
13. Poulain M, Durand F, Palomba B, et al. 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest. 2003; 123 (5):1401-1407. (Pubitemid 36549756)
14. Barbera JA, Roca J, Ramirez J, Wagner PD, Ussetti P, Rodriguez-Roisin R. Gas exchange during exercise in mild chronic obstructive pulmonary disease. Correlation with lung structure. Am Rev Respir Dis. 1991; 144 (3 pt 1):520-525.
15. Mohsenifar Z, Collier J, Belman MJ, Koerner SK. Isolated reduction in single-breath diffusing capacity in the evaluation of exertional dyspnea. Chest. 1992; 101 (4):965-969.
16. Hadeli KO, Siegel EM, Sherrill DL, Beck KC, Enright PL. Predictors of oxygen desaturation during submaximal exercise in 8,000 patients. Chest. 2001; 120 (1):88-92. (Pubitemid 32744862)
17. Mohsenifar Z, Lee SM, Diaz P, et al. Single-breath diffusing capacity of the lung for carbon monoxide: a predictor of PaO2, maximum work rate, and walking distance in patients with emphysema. Chest. 2003; 123 (5):1394-1400. (Pubitemid 36549755)
18. Knower MT, Dunagan DP, Adair NE, Chin R Jr. Baseline oxygen saturation predicts exercise desaturation below prescription threshold in patients with chronic obstructive pulmonary disease. Arch Intern Med. 2001; 161 (5): 732-736. (Pubitemid 32200228)
19. Struck J, Tao C, Morgenthaler NG, Bergmann A. Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides. 2004; 25 (8):1369-1372. (Pubitemid 39180069)
20. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem. 2005; 51 (10):1823-1829. (Pubitemid 41368172)
21. MacManus CF, Campbell EL, Keely S, Burgess A, Kominsky DJ, Colgan SP. Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization. FASEB J. 2011; 25 (6):1856-1864.
22. Pfeil U, Aslam M, Paddenberg R, et al. Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol. 2009; 297 (5):L837-L845.
23. Fitzpatrick SF, Tambuwala MM, Bruning U, et al. An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxia. J Immunol. 2011; 186 (2):1091-1096.
24. Marinoni E, Pacioni K, Sambuchini A, Moscarini M, Letizia C, DI Iorio R. Regulation by hypoxia of adrenomedullin output and expression in human trophoblast cells. Eur J Obstet Gynecol Reprod Biol. 2011; 154 (2):146-150.
25. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 175 (3):250-255. (Pubitemid 46203128)
26. Stolz D, Christ-Crain M, Morgenthaler NG, et al. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest. 2008; 134 (2):263-272.
27. Stolz D, Kostikas K, Blasi F, et al. Adrenomedullin refines mortality prediction by the BODE index in COPD - The "BODE-A" index. Eur Respir J. 2014; 43 (2):397-408.
28. Global strategy for diagnosis, management, and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease website. http://www.goldcopd. org/guidelines-global-strategy-for-diagnosis-management.html. Accessed December 13, 2013.
29. Brusasco V, Crapo R, Viegi G; American Thoracic Society; European Respiratory Society. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005; 26 (1):1-2. (Pubitemid 40945922)
30. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166 (1):111-117.
31. Medicare National coverage determinations (NCD) manual. Centers for Medicare & Medicaid Services website. http://www.cms.gov/Regulations-and- Guidance/Guidance/Manuals/Internet-Only-Manuals-IOMs-Items/CMS014961.html. Accessed December 13, 2013.
32. National coverage determination (NCD) for home use of oxygen (240.2). Centers for Medicare & Medicaid Services website. http://www.cms.gov/ medicare-coverage-database/details/ncd-details.aspx?NCDId=169&ncdver= 1&NCAId=169&NcaName=Home+Use+of+Oxygen&IsPopup=y&bc= AAAAAAAAIAAA&. Accessed December 13, 2013.
33. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer-Verlag; 2000.
34. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008; 27 (2):157-172. (Pubitemid 351193639)
35. Jackson CH. Multi-state models for panel data: the msm package for R. J Stat Softw. 2011; 38 (8):1-29.
36. Tashkin DP, Celli B, Senn S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359 (15):1543-1554.
37. Crisafulli E, Iattoni A, Venturelli E, et al. Predicting walking-induced oxygen desaturations in COPD patients: a statistical model. Respir Care. 2013; 58 (9):1495-1503.
38. Martinez FJ, Foster G, Curtis JL, et al; NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006; 173 (12):1326-1334. (Pubitemid 43900706)
39. Scott AS, Baltzman MA, Chan R, Wolkove N. Oxygen desaturation during a 6 min walk test is a sign of nocturnal hypoxemia. Can Respir J. 2011; 18 (6):333-337.
40. Jenkins S, Çeçins N. Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease. Intern Med J. 2011; 41 (5):416-422.
41. van Gestel AJ, Clarenbach CF, Stöwhas AC, et al. Prevalence and prediction of exercise-induced oxygen desaturation in patients with chronic obstructive pulmonary disease. Respiration. 2012; 84 (5):353-359.
42. Pilling J, Cutaia M. Ambulatory oximetry monitoring in patients with severe COPD: a preliminary study. Chest. 1999; 116 (2):314-321. (Pubitemid 29382113)
43. Soguel Schenkel N, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur Respir J. 1996; 9 (12):2584-2589. (Pubitemid 26407912)
44. Casanova C, Hernández MC, Sánchez A, et al. Twenty-four-hour ambulatory oximetry monitoring in COPD patients with moderate hypoxemia. Respir Care. 2006; 51 (12):1416-1423.
45. Owens GR, Rogers RM, Pennock BE, Levin D. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med. 1984; 310 (19):1218-1221. (Pubitemid 14140360)
46. Jehn M, Schindler C, Meyer A, et al. Associations of daily walking activity with biomarkers related to cardiac distress in patients with chronic obstructive pulmonary disease. Respiration. 2013; 85 (3):195-202.
47. Sin DD, Man SF. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol. 2007; 85 (1):141-147. (Pubitemid 46996112)
48. Matsui H, Shimosawa T, Itakura K, Guanqun X, Ando K, Fujita T. Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia. Circulation. 2004; 109 (18):2246-2251. (Pubitemid 38625404)
49. Qi JG, Ding YG, Tang CS, Du JB. Chronic administration of adrenomedullin attenuates hypoxic pulmonary vascular structural remodeling and inhibits proadrenomedullin N-terminal 20-peptide production in rats. Peptides. 2007; 28 (4):910-919.
50. Chatterjee AB, Rissmiller RW, Meade K, et al. Reproducibility of the 6-minute walk test for ambulatory oxygen prescription. Respiration. 2010; 79 (2):121-127.
51. Lewis CA, Eaton TE, Fergusson W, Whyte KF, Garrett JE, Kolbe J. Home overnight pulse oximetry in patients with COPD: more than one recording may be needed. Chest. 2003; 123 (4):1127-1133. (Pubitemid 36444370)
52. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011; 6:199-208.
53. Barberà JA, Roca J, Ferrer A, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 1997; 10 (6):1285-1291. (Pubitemid 27278247)